On this episode of Healthcare Americana, host Christopher Habig, CEO of Freedom Healthworks, is joined by Howard Berman, CEO of Coya Therapeutics. Together, they discuss the complexities of neurodegenerative diseases and the groundbreaking work being done to combat them. Explore the profound impact of conditions like ALS, Alzheimer’s, and Parkinson’s, and discover Coya’s pioneering approach that utilizes Regulatory T-cells (Tregs) to revolutionize therapy for neurodegeneration. Howard offers insights into Coya’s imminent breakthroughs, explains the critical role the immune system plays in all neurodegenerative diseases, and touches upon the process of working with the government to bring new treatments to the public. He also shares the tragic circumstance that occurred, which ultimately lead him to the overnight decision of leaving his career in big pharma and propelling him on this mission-based path. Finally, Howard concludes with the high expectations he has for Coya in the next 12 months. Don’t miss this enlightening discussion that sheds light on the pressing need to address the growing epidemic of neurodegenerative diseases.
Follow Healthcare Americana:
Subscribe at https://healthcareamericana.com/episodes/